Clinical trials
Completed Overweight trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2009 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2014 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 7 |
| 2024 | 7 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 32 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 5 |
| Zafgen, Inc. | 5 |
| AstraZeneca | 3 |
| University of Melbourne | 3 |
| Biomed Industries, Inc. | 2 |
| Novo Nordisk A/S | 2 |
| University of Adelaide | 2 |
| Amgen | 1 |
| Australian Catholic University | 1 |
| Carmot Australia First Pty Ltd | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Overweight | 32 |
| Obesity | 30 |
| Diabetes Mellitus, Type 2 | 7 |
| Weight Loss | 3 |
| Osteoarthritis | 2 |
| Osteoarthritis, Knee | 2 |
| Sleep Apnea, Obstructive | 2 |
| Arthritis | 1 |
| Body Weight | 1 |
| Body Weight Changes | 1 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.